• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Credit Suisse Lux Biotechnology Equity Fund

+ Add to Watchlist

CLABI1B:LX

380.08 USD 6.07 1.62%

As of 00:59:30 ET on 10/16/2014.

Snapshot for Credit Suisse Lux Biotechnology Equity Fund (CLABI1B)

Year To Date: +12.49% 3-Month: +6.30% 3-Year: +37.75% 52-Week Range: 294.73 - 409.18
1-Month: -4.20% 1-Year: +22.69% 5-Year: +23.69% Beta vs NBI: 1.02

Mutual Fund Chart for CLABI1B

No chart data available.
  • CLABI1B:LX 380.08
  • 1M
  • 1Y
Interactive CLABI1B Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CLABI1B

Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.

Inception Date: 10-05-2001 Telephone: -
Managers: IRENE BEATRICE PUETTNER
Web Site: www.credit-suisse.com

Fundamentals for CLABI1B

NAV (on 2014-10-16) 380.08
Assets (M) (on 2014-10-16) 193.63
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment 250,000.00

Dividends for CLABI1B

No dividends reported

Fees & Expenses for CLABI1B

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.20
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CLABI1B

Filing Date: 07/31/2014
Name Position Value % of Total
Gilead Sciences Inc 185,484 16,981,060 8.907%
Celgene Corp 180,276 15,711,053 8.241%
Biogen Idec Inc 42,745 14,293,501 7.497%
Amgen Inc 111,973 14,264,240 7.482%
Alexion Pharmaceuticals Inc 61,752 9,817,950 5.150%
Regeneron Pharmaceuticals Inc 28,000 8,854,160 4.644%
Vertex Pharmaceuticals Inc 94,000 8,357,540 4.384%
BioMarin Pharmaceutical Inc 114,444 7,074,928 3.711%
Incyte Corp 125,000 5,946,250 3.119%
Medivation Inc 80,000 5,938,400 3.115%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil